Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 273

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019

Open access
Awedew, Atalel Fentahun, Han, Hannah, Abbasi, Behzad, Abbasi-Kangevari, Mohsen, Ahmed, Muktar Beshir, Almidani, Omar, Amini, Erfan, Arabloo, Jalal, Argaw, Ayele Mamo, Athari, Seyyed Shamsadin, Atlaw, Daniel, Banach, Maciej, Barrow, Amadou, Bhagavathula, Akshaya Srikanth, Bhojaraja, Vijayalakshmi S, Bikbov, Boris, Bodicha, Belay Boda Abule, Butt, Nadeem Shafique, Caetano dos Santos, Florentino Luciano, Dadras, Omid, Dai, Xiaochen, Doan, Linh Phuong, Eftekharzadeh, Sahar, Fatehizadeh, Ali, Garg, Tushar, Gebremeskel, Teferi Gebru, Getachew, Motuma Erena, Ghamari, Seyyed-Hadi, Gilani, Syed Amir, Golechha, Mahaveer, Gupta, Veer Bala, Gupta, Vivek Kumar, Hay, Simon I, Hosseini, Mohammad-Salar, Hosseinzadeh, Mehdi, Humayun, Ayesha, Ilic, Irena M, Ilic, Milena D, Ismail, Nahlah Elkudssiah, Jakovljevic, Mihajlo, Jayaram, Shubha, Jazayeri, Seyed Behzad, Jema, Alelign Tasew, Kabir, Ali, Karaye, Ibraheem M, Khader, Yousef Saleh, Khan, Ejaz Ahmad, Landires, Iván, Lee, Sang-woong, Lee, Shaun Wen Huey, Lim, Stephen S, Lobo, Stany W, Majeed, Azeem, Malekpour, Mohammad-Reza, Malih, Narges, Malik, Ahmad Azam, Mehrabi Nasab, Entezar, Mestrovic, Tomislav, Michalek, Irmina Maria, Mihrtie, Gedefaye Nibret, Mirza-Aghazadeh-Attari, Mohammad, Misganaw, Awoke Temesgen, Mokdad, Ali H, Molokhia, Mariam, Murray, Christopher J L, Narasimha Swamy, Sreenivas, Nguyen, Son Hoang, Nowroozi, Ali, Nuñez-Samudio, Virginia, Owolabi, Mayowa O, Pawar, Shrikant, Perico, Norberto, Rawaf, David Laith, Rawaf, Salman, Rawassizadeh, Reza, Remuzzi, Giuseppe, Sahebkar, Amirhossein, Sampath, Chethan, Shetty, Jeevan K, Sibhat, Migbar Mekonnen, Singh, Jasvinder A, Tan, Ker-Kan, Temesgen, Gebremaryam, Tolani, Musliu Adetola, Tovani-Palone, Marcos Roberto, Valadan Tahbaz, Sahel, Valizadeh, Rohollah, Vo, Bay, Vu, Linh Gia, Yang, Lin, Yazdanpanah, Fereshteh, Yigit, Arzu, Yiğit, Vahit, Yunusa, Ismaeel, Zahir, Mazyar, Vos, Theo, Dirac, M Ashworth·2022·The Lancet Healthy Longevity

Abstract

BACKGROUND: Benign prostatic hyperplasia is a common urological disease affecting older men worldwide, but comprehensive data about the global, regional, and national burden of benign prostatic hyperplasia and its trends over time are scarce. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, we estimated global trends in, and prevalence of, benign prostatic hyperplasia and disability-adjusted life-years (DALYs) due to benign prostatic hyperplasia, in 21 regions and 204 countries and territories from 2000 to 2019. METHODS: This study was conducted with GBD 2019 analytical and modelling strategies. Primary prevalence data came from claims from three countries and from hospital inpatient encounters from 45 locations. A Bayesian meta-regression modelling tool, DisMod-MR version 2.1, was used to estimate the age-specific, location-specific, and year-specific prevalence of benign prostatic hyperplasia. Age-standardised prevalence was calculated by the direct method using the GBD reference population. Years lived with disability (YLDs) due to benign prostatic hyperplasia were estimated by multiplying the disability weight by the symptomatic proportion of the prevalence of benign prostatic hyperplasia. Because we did not estimate years of life lost associated with benign prostatic hyperplasia, disability-adjusted life-years (DALYs) equalled YLDs. The final estimates were compared across Socio-demographic Index (SDI) quintiles. The 95% uncertainty intervals (UIs) were estimated as the 25th and 975th of 1000 ordered draws from a bootstrap distribution. FINDINGS: Globally, there were 94·0 million (95% UI 73·2 to 118) prevalent cases of benign prostatic hyperplasia in 2019, compared with 51·1 million (43·1 to 69·3) cases in 2000. The age-standardised prevalence of benign prostatic hyperplasia was 2480 (1940 to 3090) per 100 000 people. Although the global number of prevalent cases increased by 70·5% (68·6 to 72·7) between 2000 and 2019, the global age-standardised prevalence remained stable (-0·770% [-1·56 to 0·0912]). The age-standardised prevalence in 2019 ranged from 6480 (5130 to 8080) per 100 000 in eastern Europe to 987 (732 to 1320) per 100 000 in north Africa and the Middle East. All five SDI quintiles observed an increase in the absolute DALY burden between 2000 and 2019. The most rapid increases in the absolute DALY burden were seen in the middle SDI quintile (94·7% [91·8 to 97·6]), the low-middle SDI quintile (77·3% [74·1 to 81·2]), and the low SDI quintile (77·7% [72·9 to 83·2]). Between 2000 and 2019, age-standardised DALY rates changed less, but the three lower SDI quintiles (low, low-middle, and middle) saw small increases, and the two higher SDI quintiles (high and high-middle SDI) saw small decreases. INTERPRETATION: The absolute burden of benign prostatic hyperplasia is rising at an alarming rate in most of the world, particularly in low-income and middle-income countries that are currently undergoing rapid demographic and epidemiological changes. As more people are living longer worldwide, the absolute burden of benign prostatic hyperplasia is expected to continue to rise in the coming years, highlighting the importance of monitoring and planning for future health system strain. FUNDING: Bill & Melinda Gates Foundation. TRANSLATION: For the Amharic translation of the abstract see Supplementary Materials section.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2666-7568(22)00213-6

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Metadata

Authors
Awedew, A. F., Han, H., Abbasi, B., Abbasi-Kangevari, M., Ahmed, M. B., Almidani, O., Amini, E., Arabloo, J., Argaw, A. M., Athari, S. S., Atlaw, D., Banach, M., Barrow, A., Bhagavathula, A. S., Bhojaraja, V. S., Bikbov, B., Bodicha, B. B. A., Butt, N. S., Caetano dos Santos, F. L., Dadras, O., Dai, X., Doan, L. P., Eftekharzadeh, S., Fatehizadeh, A., Garg, T., Gebremeskel, T. G., Getachew, M. E., Ghamari, S.-H., Gilani, S. A., Golechha, M., Gupta, V. B., Gupta, V. K., Hay, S. I., Hosseini, M.-S., Hosseinzadeh, M., Humayun, A., Ilic, I. M., Ilic, M. D., Ismail, N. E., Jakovljevic, M., Jayaram, S., Jazayeri, S. B., Jema, A. T., Kabir, A., Karaye, I. M., Khader, Y. S., Khan, E. A., Landires, I., Lee, S.-W., Lee, S. W. H., Lim, S. S., Lobo, S. W., Majeed, A., Malekpour, M.-R., Malih, N., Malik, A. A., Mehrabi Nasab, E., Mestrovic, T., Michalek, I. M., Mihrtie, G. N., Mirza-Aghazadeh-Attari, M., Misganaw, A. T., Mokdad, A. H., Molokhia, M., Murray, C. J. L., Narasimha Swamy, S., Nguyen, S. H., Nowroozi, A., Nuñez-Samudio, V., Owolabi, M. O., Pawar, S., Perico, N., Rawaf, D. L., Rawaf, S., Rawassizadeh, R., Remuzzi, G., Sahebkar, A., Sampath, C., Shetty, J. K., Sibhat, M. M., Singh, J. A., Tan, K.-K., Temesgen, G., Tolani, M. A., Tovani-Palone, M. R., Valadan Tahbaz, S., Valizadeh, R., Vo, B., Vu, L. G., Yang, L., Yazdanpanah, F., Yigit, A., Yiğit, V., Yunusa, I., Zahir, M., Vos, T., & Dirac, M. A.
Venue
The Lancet Healthy Longevity
Publisher
Elsevier BV
Published
2022-11
Volume
3
Issue
11
Pages
e754-e776
ISSN
2666-7568 (ISSN-L)
OpenAlex
W4306907106
Cited by
273
References
40
FWCI
50.95
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. https://app.cochat.ai/papers/10.1016/s2666-7568(22)00213-6
The paper
Awedew, A. F., Han, H., Abbasi, B., Abbasi-Kangevari, M., Ahmed, M. B., Almidani, O., Amini, E., Arabloo, J., Argaw, A. M., Athari, S. S., Atlaw, D., Banach, M., Barrow, A., Bhagavathula, A. S., Bhojaraja, V. S., Bikbov, B., Bodicha, B. B. A., Butt, N. S., Caetano dos Santos, F. L., . . . Dirac, M. A. (2022). The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(22)00213-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.